Dr John Kruse
Dr John Kruse
@drjohnkruse·16.8K subscribers·484 videos

Qelbree (Viloxazine) for ADHD

Posted

May 4, 2025

Views

3,632

Likes

96

Comments

55

Engagement

4.16%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

Chapters

YouTube Description

as posted by the channel

Main Chapters:

Qelbree (viloxazine) was approved in 2021 for treating ADHD, becoming the first new substance in a decade recognized by the FDA to be effective for this purpose.

Viloxazine was developed in the 1970's as an anti-depressant, and used as such in Europe for two decades. It also had orphan drug status in the US for treating narcolepsy in the mid 1980's. Originally thought to be a simple norepinephrine reuptake inhibitor, its mechanism of action remains unclear, but probably involves action on serotonin 2B and 1C receptors as well.

It appears to be as effective as other non-stimulants in the treatment of ADHD, with less likelihood of cardiovascular side effects than many stimulants and non-stimulants.

-----

Follow on Medium for hundreds of full length articles on this subject and more!

Access to Full Medium articles requires paid membership.

-----

References:

Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder (2024)

Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients (2023)

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder (2021)

Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder (2023)

Full Chapter list:

-------------------------

Psychiatrist, neuroscientist, and author John Kruse, MD, PhD presents practical, actionable, well-researched information about treatment options that scientists and clinicians recommend for adult ADHD and other mental health conditions.

Subscribe if you're curious about how neuroatypical brains can optimize their functioning in our shared, and somewhat strange, world.

ADHD topics have a pink background, and those on more general mental health topics have a purple background. A small collection of Politics related videos have an orange background.

Dr. Kruse has posted videos in the "Videos", "Live", and "Shorts", sections of this channel.

You're welcome to email him with topics you want discussed or people you think he should interview.

drjohnkruse@gmail.com

#health #mentalhealth #adhd

Guests & Subjects Covered

Main Chapters IntroADHD TakeQelbree Viloxazine QelbreeFull MediumReferences Viloxazine Extended-Release CapsulesAttention-DeficitHyperactivity DisorderAttention Deficit Hyperactivity DisorderExtended-Release Viloxazine Compared

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.